Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
603739 Qingdao Vland Biotech INC.
- 12.94
- -0.10-0.77%
Market Closed May 9 15:00 CST
3.27BMarket Cap55.06P/E (TTM)
13.13High12.86Low51.23KlotVolume13.04Open13.04Pre Close66.34MTurnover2.03%Turnover Ratio52.18P/E (Static)253.03MShares21.4052wk High1.87P/B3.27BFloat Cap9.9952wk Low14.34Limit Up253.03MShs Float29.90Historical High11.74Limit Down2.07%Amplitude7.60Historical Low0.10Dividend TTM12.95Avg Price24.74KlotAsk0.77%Div YieldTTM100Lot Size24.64KlotBid
Qingdao Vland Biotech INC. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 8.16%310.2M | 10.16%1.32B | 7.50%945.62M | 12.00%609.23M | 23.32%286.78M | 3.07%1.2B | 6.06%879.64M | 2.13%543.94M | -9.14%232.56M | 1.07%1.16B |
| Operating revenue | 8.16%310.2M | 10.16%1.32B | 7.50%945.62M | 12.00%609.23M | 23.32%286.78M | 3.07%1.2B | 6.06%879.64M | 2.13%543.94M | -9.14%232.56M | 1.07%1.16B |
| Other operating revenue | ---- | 81.41%38.97M | ---- | 99.67%16.68M | ---- | -24.41%21.48M | ---- | -54.96%8.35M | ---- | -29.80%28.42M |
| Total operating cost | 7.37%293.95M | 11.71%1.22B | 7.52%881.91M | 10.73%570.65M | 19.88%273.76M | 1.77%1.09B | 5.74%820.19M | 3.99%515.36M | -5.89%228.36M | 5.74%1.07B |
| Operating cost | 8.35%172.59M | 12.58%725.81M | 7.81%527.86M | 10.82%336.46M | 21.89%159.29M | -2.37%644.69M | 2.26%489.61M | 0.34%303.61M | -10.83%130.69M | 6.76%660.31M |
| Operating tax surcharges | 1.34%3.4M | 33.80%13.22M | 46.91%9.91M | 65.60%6.87M | 59.53%3.36M | 6.25%9.88M | 1.87%6.75M | 0.37%4.15M | -6.85%2.1M | 3.79%9.3M |
| Operating expense | 12.90%49.4M | 4.06%197.38M | -3.71%139.42M | 1.74%93.49M | 9.84%43.76M | 7.28%189.68M | 13.13%144.8M | 12.45%91.89M | -4.10%39.84M | -1.54%176.82M |
| Administration expense | 0.05%35.65M | 17.49%146.6M | 19.77%107.27M | 15.36%68.72M | 17.74%35.63M | 3.32%124.78M | 2.63%89.56M | 5.87%59.57M | 8.76%30.27M | 14.56%120.77M |
| Financial expense | -12.03%4.4M | 46.48%20.77M | 94.84%16.14M | 113.04%10.04M | 78.82%5.01M | 168.81%14.18M | 200.99%8.29M | 412.63%4.71M | 290.60%2.8M | 67.99%5.28M |
| -Interest expense (Financial expense) | -20.85%4.28M | 43.77%21.88M | 76.30%16.37M | 88.47%10.68M | 107.07%5.41M | 112.20%15.22M | 42.41%9.29M | 113.37%5.66M | 79.85%2.61M | 237.86%7.17M |
| -Interest Income (Financial expense) | 70.19%-147.21K | 3.73%-1.53M | -32.42%-1.19M | -91.36%-799.17K | -132.96%-493.76K | -140.69%-1.58M | -124.24%-901.39K | -50.08%-417.63K | -50.18%-211.95K | 7.90%-658.18K |
| Research and development | 6.65%28.49M | 6.81%118.22M | 0.13%81.3M | 7.06%55.05M | 17.90%26.72M | 8.09%110.68M | 12.37%81.2M | 2.86%51.42M | -4.57%22.66M | 1.45%102.4M |
| Credit Impairment Loss | 222.78%2.26M | 51.52%-6.47M | -44.39%-3.87M | -574.56%-1.44M | -284.50%-1.84M | 27.66%-13.34M | 61.21%-2.68M | 94.37%-212.76K | 242.59%997.14K | -135.79%-18.44M |
| Asset Impairment Loss | --167.96K | 58.83%-2.68M | 1,696.47%519.85K | --519.85K | ---- | -155.61%-6.52M | --28.94K | ---- | ---- | -34.93%-2.55M |
| Adjustment items of total operating cost | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- |
| Other net revenue | -13.33%8.34M | 41.22%25.27M | -12.90%18.7M | 4.48%16.66M | -8.28%9.62M | 22.49%17.89M | -3.82%21.47M | 0.78%15.95M | -4.43%10.49M | -60.08%14.61M |
| Fair value change income | -98.70%495 | -9.79%8.32M | -89.81%470.14K | 69.99%7.95M | --38.15K | 4,248.32%9.22M | 202.06%4.61M | 80.80%4.68M | ---- | -50.99%212.04K |
| Invest income | -63.67%1.66M | -119.32%-1.24M | -21.72%3.97M | -224.52%-3.04M | -3.47%4.58M | 96.32%6.42M | 10.42%5.07M | 162.22%2.44M | 752.83%4.74M | -54.57%3.27M |
| -Including: Investment income associates | ---- | -77.83%-8.49M | ---- | ---- | ---- | -190.85%-4.77M | ---- | ---- | ---- | -325.70%-1.64M |
| Asset deal income | ---- | 109,334.10%602.39K | 102,896.34%566.95K | 101,600.38%559.82K | 94,488.75%520.67K | -99.84%550.46 | -66.48%550.46 | -66.48%550.46 | --550.46 | 658.48%352.73K |
| Other revenue | -32.84%4.25M | 20.90%26.74M | 18.04%17.04M | 33.89%12.11M | 33.17%6.32M | -30.38%22.12M | -37.52%14.44M | -43.77%9.04M | -57.28%4.75M | -17.76%31.77M |
| Operating profit | 8.62%24.59M | 0.91%124.02M | 1.85%82.41M | 24.07%55.25M | 54.14%22.64M | 19.43%122.9M | 6.35%80.91M | -15.69%44.53M | -39.50%14.69M | -39.78%102.9M |
| Add:Non operating Income | 929.54%218.33K | 1.64%81.58K | -10.56%72.61K | -16.52%47.91K | 39.09%21.21K | -32.84%80.27K | -15.52%81.18K | -34.23%57.39K | -61.81%15.25K | -85.12%119.51K |
| Less:Non operating expense | 10,031.60%434.09K | 36.13%661.21K | -61.58%51.78K | -88.83%13.08K | -94.85%4.28K | -41.92%485.72K | -82.01%134.78K | -53.05%117.05K | -9.46%83.22K | 211.84%836.25K |
| Total profit | 7.59%24.37M | 0.77%123.44M | 1.94%82.43M | 24.32%55.28M | 54.97%22.65M | 19.87%122.5M | 7.20%80.86M | -15.55%44.47M | -39.65%14.62M | -40.38%102.19M |
| Less:Income tax cost | 41.78%7.79M | 59.24%31.27M | 56.03%21.37M | 70.94%12.97M | 165.76%5.49M | 17.06%19.64M | 4.47%13.69M | -25.36%7.59M | -52.78%2.07M | -21.26%16.78M |
| Net profit | -3.36%16.59M | -10.39%92.17M | -9.08%61.07M | 14.73%42.31M | 36.73%17.16M | 20.43%102.86M | 7.77%67.17M | -13.20%36.88M | -36.76%12.55M | -43.10%85.41M |
| Net profit from continuing operation | -3.36%16.59M | -10.39%92.17M | -9.08%61.07M | 14.73%42.31M | 36.73%17.16M | 20.43%102.86M | 7.77%67.17M | -13.20%36.88M | -36.76%12.55M | -43.10%85.41M |
| Less:Minority Profit | 57.89%7.01M | 33.34%29.53M | 70.72%20.22M | 139.54%12.96M | 123.17%4.44M | 42.27%22.15M | 46.03%11.84M | 6.48%5.41M | 12.73%1.99M | -11.15%15.57M |
| Net profit of parent company owners | -24.73%9.58M | -22.39%62.64M | -26.17%40.85M | -6.73%29.35M | 20.45%12.72M | 15.56%80.71M | 2.05%55.32M | -15.87%31.47M | -41.59%10.56M | -47.32%69.84M |
| Add:Adjusted items effecting net profit of parent company owners | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- |
| Earning per share | ||||||||||
| Basic earning per share | -20.00%0.04 | -21.88%0.25 | -27.27%0.16 | 0.00%0.12 | 25.00%0.05 | 14.29%0.32 | 0.00%0.22 | -20.00%0.12 | -42.86%0.04 | -48.15%0.28 |
| Diluted earning per share | -20.00%0.04 | -21.88%0.25 | -27.27%0.16 | 0.00%0.12 | 25.00%0.05 | 18.52%0.32 | 0.00%0.22 | -20.00%0.12 | -42.86%0.04 | -50.00%0.27 |
| Other composite income | 119.33%1.26M | -150.82%-58.42K | -124.03%-57.26K | 92.80%-4.24K | 166.91%573.11K | -78.51%114.95K | -2.06%238.32K | -1.01%-58.82K | 90.60%-856.5K | |
| Other composite income of parent company owners | ---- | 117.88%1.27M | -146.27%-41.48K | -122.29%-39.65K | 93.69%-2.85K | 162.45%583.78K | -78.42%89.65K | -6.17%177.87K | -10.67%-45.11K | 89.70%-934.84K |
| Other composite income of minority owners | ---- | -40.38%-14.98K | -166.94%-16.94K | -129.13%-17.61K | 89.85%-1.39K | -113.62%-10.67K | -78.84%25.31K | 12.42%60.45K | 21.50%-13.71K | 323.11%78.34K |
| Add:Adjusted items effecting composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13.71K | ---- |
| Total composite income | -3.33%16.59M | -9.67%93.43M | -9.32%61.01M | 13.84%42.25M | 37.49%17.16M | 22.32%103.43M | 7.04%67.28M | -13.13%37.12M | -36.94%12.48M | -40.03%84.55M |
| Total composite income of parent company owners | -24.71%9.58M | -21.38%63.91M | -26.36%40.81M | -7.38%29.31M | 21.10%12.72M | 17.97%81.29M | 1.44%55.41M | -15.82%31.65M | -41.78%10.5M | -44.20%68.91M |
| Total composite income of minority owners | 57.94%7.01M | 33.33%29.52M | 70.21%20.2M | 136.57%12.94M | 124.65%4.44M | 41.49%22.14M | 44.22%11.87M | 6.54%5.47M | 13.07%1.98M | -10.53%15.65M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting